Acetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Suppression of Hepatic De Novo Lipogenesis and Significant Improvements in MRI-PDFF, MRE and Markers of Fibrosis after 12 Weeks of Therapy in Patients with NASH

Press/Media: Press / Media

PeriodMay 23 2017

Media coverage

1

Media coverage

  • TitleAcetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Suppression of Hepatic De Novo Lipogenesis and Significant Improvements in MRI-PDFF, MRE and Markers of Fibrosis after 12 Weeks of Therapy in Patients with NASH
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date5/23/17
    PersonsFred Poordad, Eric J Lawitz